Objective: To validate the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) 12-item tool against the 36-item version for measuring functioning and disability associated with pregnancy and the occurrence of maternal morbidity.
| INTRODUCTION
According to the United Nations World Report on Disability, more than 1 billion people in the world live with some form of disability, of which nearly 200 million experience considerable difficulties in functioning.
Globally, people with disabilities have poorer health outcomes, lower educational achievements, less economic participation, and higher rates of poverty than people without disabilities. 1 However, the burden of ill health associated with pregnancy-related and obstetric com-
plications is yet to be completely understood because of the broad impact of short-and long-term consequences. 2 Functioning and disability among women of reproductive age is poorly studied. The use of a simple and effective tool to identify and measure disability in the postpartum period is key to improving maternal health worldwide. 2, 3 The WHO has made efforts to address the problem of identifying and assessing disability and functioning by establishing an international classification system, the International Classification of Functioning, Disability and Health (ICF). 4 All standard instruments for measuring disability and health needed to be linked conceptually and operationally to the ICF to allow comparisons across different cultures and populations using these new concepts. Using the ICF's conceptualization of disability, WHO developed a new tool-the WHO Disability Assessment Schedule (WHODAS)-to measure difficulties in performing daily activities in a more simplified manner. Like ICF, the tool was designed to "assess the limitations on activity and restrictions on participation experienced by an individual, irrespective of medical diagnosis". 5 The WHODAS tool was refined to include cross-cultural measurement of health status and to respond to calls for improving the scope and cultural adaptability of the original WHODAS. Its second version (WHODAS 2.0) was presented as a general measure of functioning impairment and disability in major life domains. The WHODAS 2.0 instrument intends to measure activity function and participation in daily activities in the 30 days preceding its application. 5, 6 The instrument has three versions, two of which were compared in this analysis. The complete 36-question version (WHODAS-36) was administered, and the results of the abbreviated 12-question version (WHODAS-12) were compared with those of the full version simply by extracting and analyzing the relevant subset of 12 questions. The possibility of using a shorter version of the instrument, the WHODAS-12, is appealing when planning population screening surveys; however, WHODAS-12 has neither been tested nor validated among pregnant women. For each domain of the original WHODAS-36, the 12-item version includes two sentinel items with good screening properties that identify over 90% of individuals with mild functioning impairment, based on all 36 items, in general populations.
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WHODAS 2.0 was translated into, culturally adapted to, and validated for various languages, including Brazilian Portuguese, for a study that implemented it among postpartum women with and without severe maternal morbidity (SMM). 7, 8 This retrospective cohort study included 638 women who delivered at a tertiary public hospital in Brazil. Women with SMM showed increased WHODAS-36 scores (functioning impairment) compared with women without SMM. 9 The objectives of the current analysis were to compare and validate the abbreviated WHODAS-12, using the complete WHODAS-36 as the reference, for assessing postpartum disability among women (both with and without maternal morbidity) who delivered up to 5 years before assessment.
| MATERIALS AND METHODS
This is a secondary analysis of the Brazilian retrospective cohort study, known as COMMAG, on the long-term repercussions of SMM on women who delivered at a tertiary maternity unit (between July 2008 and June 2012). 9 The methods have previously been published. 9, 10 Briefly, WHODAS 2.0 was applied to a cohort of women with and without the diagnosis of SMM (potentially life-threatening conditions and maternal near-miss incidents), according to WHO standard definition and criteria. 11 Score calculations for the analysis used the WHODAS "item-response-theory" (IRT) based scoring. 5 After obtaining individual informed consent, face-to-face interviews were carried out by healthcare professionals specially trained for the study. All women meeting the SMM criteria who delivered during the study period were invited to participate and a control group
(1:1 rate) was also selected. For each woman who experienced SMM ("exposed" group), a woman without SMM ("nonexposed group"), irrespective of other less-severe morbidities, and who delivered the same year and at the same institution, was recruited. as maintenance of personal dignity. 6 Response options for every question are: no difficulty, little, moderate, severe, and extreme difficulty.
To study WHODAS-12, the questions common to WHODAS-36
were labelled from S1 to S12 ( proportionally converted to a score also ranging from 0 to 100.
Additionally, we compared the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles (with their respective 95% confidence intervals) of total score for both groups (with and without morbidity), using Participating women were initially approached and interviewed by phone using the computer assisted telephone interview (CATI) unit, at which time they were invited to the hospital for a visit. During this visit, additional evaluations were performed, including an assessment of the corresponding child.
| RESULTS
The COMMAG study enrolled 638 women, 323 without and 315 with severe maternal morbidity. Their general characteristics are published elsewhere. 9 In total, 631 women completed the entire WHODAS-36 instrument, which in turn contains all the WHODAS-12 questions.
Missing information in any domain limits the calculation of the total scores and therefore seven women were excluded from the analysis.
The results presented compare the 36-item and 12-item scores for all 631 women with complete data; the differences between scores in women with morbidity or without morbidity are explained in further detail elsewhere in this Supplement. 14 In comparing the two instruments, the median of WHODAS-36
and WHODAS-12 total scores as well as those for each domain were assessed. The values for the total scores for the 631 women were 13.04 and 11.76 (P<0.001), respectively ( Table 2 ). The domain scores (Fig. 3) . However, the analyses of mean differences and difference in variance by domains were different from those observed for the total score, showing significant variance between domain scores of the two tool versions (Fig. 4) . The mean difference ranged from 0.231 (domain 4) to −4.259 (domain 2). Figure 5 shows the percentile scores of the total sample, and a breakdown of scores by women's history of SMM using a boxplot. Although there was a statistically significant difference (P=0.003) when comparing the 36-and 12-item scores in the 25th percentile for women with SMM and the 50th percentile for women without SMM, we considered these differences very small and not clinically relevant.
The CFA with six factors showed that both questions from 
| DISCUSSION
Our validation study indicated that WHODAS-12 is a good substitute for WHODAS-36. We found a very high correlation between the total scores of WHODAS-12 and WHODAS-36, but relatively poor agreement at the sublevel of specific domains. Reassuringly, the agreement between the versions did not seem to vary significantly according to different levels of functionality (different percentile values). Finally, the confirmatory factor analyses validated the internal consistency and reliability of WHODAS-12.
The use of WHODAS-36 in 631 women (315 women who experienced SMM and 323 who did not) (COMMAG study) 9 has provided us with a great opportunity to assess the abbreviated 12-item version, enabling the validation of a potentially reproducible, manageable, short, and reliable instrument to assess women's functionality. The utilization of standardized instruments is key for evaluating and comparing the long-term consequences of SMM across studies, sites, and complication diagnoses. This complex challenge is essential for advancing the promotion of maternal health, particularly in the context of the Sustainable Development Goals, which place emphasis on the whole woman and her ability to work and participate in economic and social activities. These efforts follow WHO's standardization of the concepts of and criteria for "maternal near miss" and "potentially life-threatening" in 2009, 11 which led to calls for similar standardization efforts for less-severe maternal morbidities and their consequences during and after pregnancy.
3,16
The 12-item version of WHODAS 2.0 has a similar structure to WHODAS-36, and comprises two questions for each domain, one with low and the other with high complexity regarding the functionality (domain) that is being assessed. 5 When applied to a general F I G U R E 1 Correlation between the full and short version scores of the WHODAS 2.0 (n=631). population, the short version has shown high correlation and agreement with WHODAS-36, yet it requires significantly less time for its implementation (about 5 minutes)-a clear potential advantage of the shorter version. 5 The statistically significant difference between the median WHODAS-12 and WHODAS-36 scores is to be expected considering the relatively large sample size of the COMMAG study. Minor differences are more likely to be statistically significant in large studies, although, in this case, it seems clinically irrelevant, given the overall low scores presented across the entire group of 631 postpartum women.
F I G U R E 2
The fact that some questions did not group as expected in the CFA may be a result of the development of the WHODAS-36. Originally, it was meant to identify self-perception of multidimensional disabilities using the total score or individual scores for each of the six domains. 6 Questions in domains 4 and 6 were not grouped with the same factor in the CFA, as was expected (and as we found) with questions in the other domains. Questions D61a and D65a were originally part of a different matrix of the ICF instrument, addressing different aspects of functionality such as community, social and civic life (Question D61a), and mental function (Question D65a), which could explain the differences in the CFA grouping for these questions.
According to our analyses, even when considering the WHODAS total score percentiles for women with or without SMM, the WHODAS-12 total score seemed to agree with that of the full version.
Though our analysis focused on comparing the 36-and 12-item scores across all women, regardless of morbidity status, the subanalysis was undertaken to ensure that there would be no differences regardless of the broad range of values presented. The only two statistically significant differences between WHODAS-12 and WHODAS-36 percentiles were found in the 25th and 50th percentiles, for SMM and no morbidity groups, respectively, with low overall scores, most likely with no clinical significance. However, future studies should address the issue of percentile cut-off points for WHODAS score among postpartum women and its association with impaired functioning.
Additionally, the mean difference of Bland-Altman analyses of the total score demonstrated that the short version may not under-or overestimate the score generated by WHODAS-36. In contrast, the scores of each WHODAS-12 domain showed good correlation but not agreement with those of WHODAS-36, as previously described. 5, 6 Therefore, although the short version might not identify specific disabilities, it showed equivalent performance in evaluating functional WHODAS-12 is a short version of a more refined and robust instrument, composed of selected questions from the WHODAS-36, thus, a high correlation between the two versions is not surprising. The Bland-Altman analysis is a useful method to address the agreement between the versions by constructing limits of agreement calculated using the mean and the standard deviation of the two scores 17 and has been used before to validate quality of life and functioning instruments. 18, 19 A study of correlation, instead of calculating the variance of the average scores (study of the differences),
is occasionally performed to address agreement between different instruments, but it can be considered a misleading approach for this purpose. 
